Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07015593

Patient Journey in Advanced Gynecologic Cancers

This is a mixed-methods survey study including a 2-phased sequential-explanatory design. This study is to understand the patient journey in conventional therapy for newly diagnosed stage III or IV CC or EC in China, including ①patients' treatment decision making factors and treatment experiences and ② patients' unmet needs during post-treatment surveillance.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Genital Neoplasms, Female Endometrial Carcinoma Endometrial Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Neoplasms Neoplasms by Site Urogenital Diseases Urogenital Neoplasms Uterine Cervical Diseases Uterine Cervical Neoplasms Uterine Diseases Uterine Neoplasms

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Ying Zhou, Hefei, Anhui, China

Loading trial locations.

About this study

This is a mixed-methods survey study including a 2-phased sequential-explanatory design: Phase 1, Qualitative interview will be done first to explore the treatment decision factors, treatment experiences and unmet needs during post treatment surveillance, to provide components and inform the quantitative data collection. Phase 2, quantitative survey to collect data on a larger scale and allow a statistical generation of the qualitative findings.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 or older
  • Newly diagnosed stage III or IV CC or EC
  • Completed their initial conventional therapies which must include at least chemotherapy, radiotherapy or a combination between Dec. 2022 to Dec. 2024 and the therapies were within 6 months after diagnosis.
  • Told by their physician that their disease is stable.
  • Patients must have informed consent form (ICF) signed for the study.

Exclusion criteria

  • Previously treated with targeted biologic therapy anti-PD-1, anti-PD-L1, or anti PD-L2 agent or with an agent directed to another stimulatory or co-inhibitory T-cell receptor.
  • Previously participated in or participating in a clinical trial.
  • Patients who received another line of therapy after initial therapy.
  • Unable or unwilling to provide informed consent.
  • Not fluent in local language.
  • Indicates or exhibits hearing difficulties, which would make a conversation challenging.

Treatment and study plan

interview

Other

30 for Qualitative interview and 750 for quantitative survey

Primary outcomes

  1. Treatment decision making

    Time frame: 1 day. At the time of the interview.

    • Information seeking in treatment decision
    • Treatment decision making factors
    • Clinical trial awareness

  2. Initial treatment experiences

    Time frame: 1 day. At the time of the interview.

    • Influence of treatment on daily life and work
    • Information and education during treatment
    • Coordination of care
    • Overall impression on care received and doctor/nurses' availability

  3. Unmet needs and gaps from diagnosis to post-treatment surveillance

    Time frame: 1 day. At the time of the interview.

    • Psychological and emotional needs
    • Social support needs
    • Healthcare needs
    • Gaps during follow-up care

Study contacts

Contact information is provided by the study sponsor or research team.

Gang Chen

CONTACT

[email protected]

086-027-83662681

Sponsors and collaborators

Lead sponsor

Tongji Hospital

Other

Registry information

Official study title

Patient Journey in Conventional Therapy for Primarily Treated Advanced Gynecologic Cancers in China

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jun 11, 2025
Registry last updated
Jun 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.